Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine

Laura Téblick, Severien Van Keer, Annemie De Smet, Pierre Van Damme, Michelle Laeremans, Alejandra Rios Cortes, Koen Beyers, Vanessa Vankerckhoven, Veerle Matheeussen, Renee Mandersloot, Arno Floore, Chris J L M Meijer, Renske D M Steenbergen, Alex Vorsters

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)


The potential of first-void (FV) urine as a non-invasive liquid biopsy for detection of human papillomavirus (HPV) DNA and other biomarkers has been increasingly recognized over the past decade. In this study, we investigated whether the volume of this initial urine stream has an impact on the analytical performance of biomarkers. In parallel, we evaluated different DNA extraction protocols and introduced an internal control in the urine preservative. Twenty-five women, diagnosed with high-risk HPV, provided three home-collected FV urine samples using three FV urine collection devices (Colli-Pee) with collector tubes that differ in volume (4, 10, 20 mL). Each collector tube was prefilled with Urine Conservation Medium spiked with phocine herpesvirus 1 (PhHV-1) DNA as internal control. Five different DNA extraction protocols were compared, followed by PCR for GAPDH and PhHV-1 (qPCR), HPV DNA, and HBB (HPV-Risk Assay), and ACTB (methylation-specific qPCR). Results showed limited effects of collection volume on human and HPV DNA endpoints. In contrast, significant variations in yield for human endpoints were observed for different DNA extraction methods (p < 0.05). Additionally, the potential of PhHV-1 as internal control to monitor FV urine collection, storage, and processing was demonstrated.

Original languageEnglish
Article number1989
Issue number7
Publication statusPublished - 1 Apr 2021


  • Cervical cancer
  • Extractions
  • First-void urine
  • Genotyping
  • HPV
  • Human papillomavirus
  • Optimization
  • Self-sampling

Cite this